BSE Live
Dec 03, 15:40Prev. Close
260.80
Open Price
260.80
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 03, 15:56Prev. Close
261.65
Open Price
261.65
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Indoco Remedies (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 18.45 | 18.44 | 18.43 | 18.43 | 18.43 | |
| Total Share Capital | 18.45 | 18.44 | 18.43 | 18.43 | 18.43 | |
| Reserves and Surplus | 1,084.91 | 1,108.18 | 1,008.59 | 885.87 | 750.50 | |
| Total Reserves and Surplus | 1,084.91 | 1,108.18 | 1,008.59 | 885.87 | 750.50 | |
| Total Shareholders Funds | 1,103.36 | 1,126.62 | 1,027.02 | 904.30 | 768.93 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 336.89 | 203.60 | 143.50 | 95.88 | 96.94 | |
| Deferred Tax Liabilities [Net] | 9.85 | 10.00 | 6.18 | 10.67 | 0.00 | |
| Other Long Term Liabilities | 21.17 | 24.66 | 22.40 | 18.37 | 14.44 | |
| Long Term Provisions | 34.88 | 33.47 | 33.33 | 31.64 | 27.73 | |
| Total Non-Current Liabilities | 402.79 | 271.74 | 205.41 | 156.57 | 139.10 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 401.10 | 293.25 | 171.00 | 148.32 | 116.32 | |
| Trade Payables | 147.38 | 118.97 | 126.45 | 135.32 | 115.02 | |
| Other Current Liabilities | 101.46 | 101.76 | 80.33 | 95.65 | 130.32 | |
| Short Term Provisions | 45.07 | 48.28 | 49.45 | 47.42 | 46.88 | |
| Total Current Liabilities | 695.01 | 562.25 | 427.24 | 426.70 | 408.54 | |
| Total Capital And Liabilities | 2,201.16 | 1,960.61 | 1,659.67 | 1,487.57 | 1,316.57 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 670.62 | 635.34 | 595.49 | 531.82 | 528.38 | |
| Intangible Assets | 83.76 | 96.99 | 65.97 | 23.16 | 41.53 | |
| Capital Work-In-Progress | 181.37 | 92.50 | 54.36 | 52.82 | 25.12 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 980.17 | 846.78 | 774.03 | 676.52 | 638.01 | |
| Non-Current Investments | 51.96 | 51.96 | 18.90 | 2.46 | 2.45 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 19.28 | |
| Long Term Loans And Advances | 120.25 | 90.86 | 6.05 | 1.41 | 0.96 | |
| Other Non-Current Assets | 93.31 | 70.80 | 53.64 | 34.40 | 33.92 | |
| Total Non-Current Assets | 1,245.69 | 1,060.39 | 852.62 | 714.79 | 694.62 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 7.24 | 1.00 | 0.00 | 0.00 | |
| Inventories | 362.86 | 310.42 | 325.99 | 310.52 | 237.81 | |
| Trade Receivables | 374.05 | 408.02 | 350.82 | 297.00 | 233.58 | |
| Cash And Cash Equivalents | 12.03 | 16.94 | 12.40 | 19.21 | 14.05 | |
| Short Term Loans And Advances | 19.88 | 1.48 | 0.69 | 0.54 | 0.40 | |
| OtherCurrentAssets | 186.64 | 156.12 | 116.16 | 145.52 | 136.11 | |
| Total Current Assets | 955.47 | 900.21 | 807.05 | 772.78 | 621.95 | |
| Total Assets | 2,201.16 | 1,960.61 | 1,659.67 | 1,487.57 | 1,316.57 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 383.32 | 347.90 | 83.15 | 60.27 | 55.72 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 1.58 | 1.55 | 1.92 | 1.61 | 126.96 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | -- | |
| Other Earnings | 5.79 | 8.38 | 7.92 | 6.56 | 542.64 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 6.14 | 6.14 | 6.14 | 6.14 | 6.14 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 51.96 | 51.96 | 18.90 | 2.46 | 2.45 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | 7.24 | 1.00 | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
12.11.2025
Indoco Remedies Standalone September 2025 Net Sales at Rs 442.12 crore, up 11.5% Y-o-Y
07.11.2025
Indoco Remedies Consolidated September 2025 Net Sales at Rs 484.67 crore, up 12.02% Y-o-Y
25.07.2025
24.07.2025
Indoco Remedies Consolidated June 2025 Net Sales at Rs 437.89 crore, up 1.48% Y-o-Y
12.11.2025
Indoco Remedies Standalone September 2025 Net Sales at Rs 442.12 crore, up 11.5% Y-o-Y
07.11.2025
Indoco Remedies Consolidated September 2025 Net Sales at Rs 484.67 crore, up 12.02% Y-o-Y
24.07.2025
Indoco Remedies Consolidated June 2025 Net Sales at Rs 437.89 crore, up 1.48% Y-o-Y
24.07.2025
Indoco Remedies Standalone June 2025 Net Sales at Rs 392.53 crore, down 2.22% Y-o-Y
12.07.2023
Indoco Remedies Q1 PAT may dip 0.1% YoY to Rs 38.5 cr: Nirmal Bang
17.01.2023
Indoco Remedies Q3 PAT seen up 46.1% YoY to Rs 482 cr: Nirmal Bang
08.07.2022
Indoco Remedies Q1 PAT seen up 4.4% YoY to Rs 41.4 cr: Prabhudas Lilladher
14.04.2022
Indoco Remedies Q4 PAT seen up 52.9% YoY to Rs 38.2 cr: Prabhudas Lilladher